Protein kinase inhibitors
US9822120B2 · kind B2 · utility
0Cited by
0References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 20, 2014 |
| Grant date | Nov 21, 2017 |
| Priority date | — |
| Expiry date | Nov 20, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel family of protein kinase inhibitors of Formula I:as well as to the processes of preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative, inflammatory, autoimmune or infectious diseases, disorders, or conditions in which protein kinase activity is implicated.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.